The success of Viagra initially sparked a boom for major pharmaceutical companies, but recent changes present a complicated scenario for shareholders. Generic alternatives are reducing profits, and continued litigation https://estellejdgl511516.free-blogz.com/88746905/the-blue-pill-and-pharma-a-volatile-play